{"ticker": {"uuid": "4671d9b0-cfe6-4289-a9c5-3334d8b946be", "symbol": "GILD", "name": "Gilead Sciences, Inc.", "exchange": "VIE", "country": "AT", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNeXdaLWxrMGF4NG5FWTk5YVB0UDVLb1lJWXlFQWxZcHQzcG4xRkxpRFdZa2ZQM2YyUHNGUDQyZmtDQzM0TjRBZDFHMW81d1hfR1ZQMHE1ZzJJRjdEY0NpeTJWNk1lcDYySlE1RG0zelZ3TkNZa0F3NnFPTHg3Sjc1aENJV1prUlYtNFROVDgxMVZJd2FYUlg2bVc1cw?oc=5", "source_name": "Market source", "published_at": "2026-07-17T22:00:04+00:00", "published_display": "17 Jul 2026 22:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Inc (GILD) Stock Up 3.5% but GF Value Says Overv", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOc2ItdkhkVzNwMGdOYjZWX1Q2dFFXNzRBT1h5SzJmWGl3QVFfNkhTR2FuU1B5RVUwQk9obVpqT0pPdzNzeWRfTDJxbzZQVjhBMkpCVTVpUi1aelZET2ZiOGhFalNrRjVJVGhZc1c5NG9mamcySXNmaE5nRm1oZnNfMlUwT0dQZE51SHcyOUR3SG15WFhrOElXeVFlbGw5VmJfbkhEYzhPVWl2ajUzZ05RV180eTJ0eDVmMnlPeU1EQkx4MEdDcy0yQzBHYw?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-16T21:35:27+00:00", "published_display": "16 Jul 2026 21:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences (NASDAQ: GILD) exec trades 3,000 shares under 10b5-1 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOZFYxNFltWHNNWXR0X0djdnRuVmRIV1IxLVdpRUpBOUZkZUZkNkkzQUJpZVAyVXFmNy1sRVVBdnpQWDlrTlNyZXZiaElvOHZuYjFuNHZnM1V0SUFqal9VNTNUX0kwZWx3b0JiOF9HVUpSS2J4WXZES3RWd0dOVHlhT3l4U3AxbVZIWWppeXVCUlhhYTZLUkpLV3V5SkY5UERINnFNcXBlSzFvelZZZktUaUo0RQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-16T20:55:08+00:00", "published_display": "16 Jul 2026 20:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Planned 3,000-share sale by Gilead (NASDAQ: GILD) shareholder Johanna Mercier", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNazZnaTl3TmFwNDR3MVdGc3h5eVNtbG82SFFaR2FvWU9iY3VCWlk0d0lVc2Rsb3kzamM0ck52aFhUVVRjc0RvUXlxVnBHd0tRUnlMaGFLbUtyV2c5VG0wV09HaVBQRHJYdE4yZy1ndk9uMFBJRHVwekQzb25DVjNoVGRiQkZDZ2FwTnRENXRSc2pTNERxOUxUMWp3OG0?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T20:13:43+00:00", "published_display": "15 Jul 2026 20:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences, Inc. (GILD) Stock Analysis: Promising 21.93% Upside Amid Strong Buy Ratings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxPLUE4TjFuWVFnYXp6R2NkZlhUblVRRkw5NTRpTGt0ZGhzZnBXQ09ZREFvTndDYTBEeDJveC1zMGk0R09Zb3EyNllpVm9vRmdtM2k2T3ByMy1uNFpTWENNT0p2TmxRcnlmd0E3bEFPbTM1eGN2Z1czNnY3UG0tdTF0ZUdhNXYxMnFkc0NwRVNyMlZENkNac0lvMHgtaGx1YkRjc2dEbmcxN21KNFZ3cHpHTGViOGVjMDIya1lmWkdPa29HaFI5VE5JazVQUi1GUTdESmJF?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:12:07+00:00", "published_display": "13 Jul 2026 09:12", "sentiment": "positive", "sentiment_pct": 95, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQclR2UzJHMm1iZG44T2dzUFpGQmh5aDVsYmI2ejZkVFk1amV2Y29QbmFCTEdzQXJvMzYwYzJoY2dvRV96RTJxQkt2dUJCV2pobDN0YnpHTmx5TlA3TnA2ZHdRM29KRkZJRjFxNEk3X3piWGFzU0FhV1ZabkFYcXZPcVNpMlpNYTFaelY5a3BnTkFfM0tBTDBsTmNPdlM?oc=5", "source_name": "Market source", "published_at": "2026-07-10T22:00:03+00:00", "published_display": "10 Jul 2026 22:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead (GILD) Stock Looks Below Fair Value But Earnings Already Look Priced In", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-09T07:00:00+00:00", "published_display": "09 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will Trodelvy\u2019s First-Line TNBC Approval Redefine Gilead Sciences\u2019 (GILD) Oncology-Led Investment Narrative?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQb1Y3U09pU3plcjhBLVR4YnlEWmpXY3dFRHI4NXlnck5mMjN2WTQ3X2IxYVlULUVSVGM2T1lFY2xIb0VqaE9rZ1NkWTBKS3FMTFpReDM5MlBZcEZfQ3lrNUxGNl9nRnBDV2cybE5LTUFJNUdIdklTRVRvbWNobkpkbU1ibDFXVkhGdjEtU2ZhdGJoUFBibldISDBB?oc=5", "source_name": "Market source", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Could This FDA Milestone Unlock Gilead\u2019s (GILD) Next Big Growth Driver?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQT29NS01sMmtTVjF4MDhFYXpGUU9yMTFVSjFIMXRkRGYxMEZXR294X2ZfU2lNbEhPQ1Qyd1hxM0JjUm00UDFfOVJEQk8xVWp3QldqRXVLb0RIZVFPdjNFUnhwS2hwbGhfVGliS0JoQzM0b3c5ZjFwQXRXNkcyS1VxRVpYMktLX2plTGdzbWtkVTUxemtfZHlCcTRn?oc=5", "source_name": "Market source", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Stock (GILD) Opinions on Recent Congressional Insider Activity", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPQk1DTTdDeWFIb0JSZWdIamtYVzlxcnJ5THpBM2lfR0VLQ1lqamRMVS16eThoOUcyZjA3UmpNTkVlVzdsYVJtV04tUy05S1NVQkZ5Q2hMa1NzUDQxUThNcU5Qc1hGSTV3NUs4eEg5azhEX0xyaWJGQm93UmFnejg2bk5UdUM3bGs2bWV6YTZ4WkJRX1RlTFR5QUI1TWNBZFpUZlMxekZYMHY4UmV2YlNHSHM1aTBpdw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences (GILD) Stock Falls Amid Market Uptick: What Investors Need to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQZ3RhTlFnWC1qTkw3YXFtQ0pBSmEtYW8zRGdPUzhJNVhQQjhBUmtlRkszQzJNaGM3MXlYb0tmV0tWWHNscG8yV1pIaXV0NnJLRVhpaF9Ub3NWYWxLOUdhQ2JrSnlkSnBHenloWGsxRUtDaHhReHNkZWVEVTA5di01ZmI3QVRVX09SREwzQkJfSUJVNGNEM1lrUVRsR3hrdw?oc=5", "source_name": "Market source", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reassess Gilead Sciences (GILD) After Strong Multi Year Share Price Gains", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNeV9feXBaekdJMVZzOEdEQzByUG1UTW0wdFRNYnhvOUxyWXR3ZDNIWWZrbmlCVEJXYWtFS1hXZndLT1g1VFVJVHlyNmNBZ0VXVVhKYVMzd2t1NS05dVZBbGcwVHI1b3NaRk5ZOEhoMW1yeTdxdWNhR0FrWFpmUUlOcHg3UkJmMUJDSHl1bW0yWWk1cm9tZmNCb21KUGo3NENP?oc=5", "source_name": "Market source", "published_at": "2026-05-23T07:00:00+00:00", "published_display": "23 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Just Told Investors What to Watch Before December 23. Here\u2019s What the Data Says About GILD Stock.", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQMy1FZks3blJfcHlFUXMxclRvdWtELUZ1Vk80amFiMlJKUGdIamE3UjJmX3JmOXpUN2ZTRXBEWm5JdF9KejJXMW5DZ1k5MDlydTZUdkVxUlVUQ1JIN3I0WVowTlRRS1dscGtKOC1tQjNLZjd5dGNEanZweFp3UUsxc193blRFZjR2WjFMTVBvbUc1NS1Td29wZ0U2azEwR3IwZTdlMk9IdUhVWllacHFmVl9lR2RJNThRbWhEMjZIV2x2RUpieW83VE4xTE1mb0dmb0E?oc=5", "source_name": "TIKR.com", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Flash (GILD) Gilead Sciences, Inc. Posts Q1 Adjusted EPS $2.03 per Share", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPYnNLU0htTl9FcTZGaFJuYlhSMGplVmUxSVkxS0ZBRkJXZ0tjQk5wNVR0SDdSMGN4aklSRHFmcXNqQkZTZDJvNUhEMGF3cXVOWFI2a3dGemlIOXMtM0NIRG9LejRXdVRicmV1Rm5qQWx5Y1pENnRnXzRpWXlHNXVMY1k4RlZYWlVRNVk0ejA1bDBTSDNwVjUtU0FhOXZRcF9LRVY5WHJkX3Q1ZlZxY3FGMU1ha3BIQWJpYmxCUTBRRGJhMUczajRXcg?oc=5", "source_name": "marketscreener.com", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences CEO Daniel O\u2019Day sells over $1.29m in stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQQnJpbXFWRlo2a2NaaDVUTVhhdHJZU0ozLVFJOGREVEFqVXZoTV9XbWRabHJxYVRXcF93bGN0UWFyc0lwWFdVZUZoVnBEMkNqZ0xUVFliU05Kb2pKZVVoV0FqYVJtaGIyRDBhX3Z5eWZrSnJsSmhScVRHNGZjNDYxRWpUVHVENjJsYUZ6WkdIalRiNUpsTDdrWDZ4VTd1c0VPNWRpYThkYy1pdVZCM210dnFjRUJ3VFVFUmlhV2V3?oc=5", "source_name": "Investing.com", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences (GILD) Stock Lands $7.8B Arcellx Deal \u2014 Is This the Buy Opportunity?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQTUtvY0RKaUd0aG1LUC1YRC1KVHZULTFJa1ZmQ2kxOWlBT25oZ0tpQUVUeFJfclBXQWpWaTZ4U0x4b0JXVFEwYTRDQmNfc2JnczgxUjQzQVhjZGRialRfSkZfMDBmMW41Wm56UkJKdW4wR0R4Q1pGY3ZQazUxUzFBUDVTOWNvT1g4MnZLRk9jd21xQzFQWHZmSHE2REk4bktvSGdhV1ln?oc=5", "source_name": "CoinCentral", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Inc. (GILD): Growing Popularity as Defensive Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOMS1kN2xmaTh4MTlPODdvOE12di05bS1RbFhpNHg2dDJGSXlZYXV1T2MzNEYzZUMwQnB2YWZVNnZEdE51SjdFdE1nSDRRajh3Xzd4V2x1Smc1NTVFUG0xQlBjRU1ZbWUtUWE2VG03VUx2dXE0Unk1R2Nfc0VVRkFpZkh2LVZZQmlTM1lBem5xYWxVeFNUYnlCbkNIdEdEQQ?oc=5", "source_name": "Market source", "published_at": "2026-04-26T07:00:00+00:00", "published_display": "26 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences : Publishes 2025 Responsible Business and Impact Report, Highlighting Momentum Toward 2030 Ambitions", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxQZE95dkczUkh1bG05TU1uaFlPMGtZTktFSEo5djhzU1BiUEdHd3lLeTB0bDJNOWZodmY1SUlVZ0NaQUE4RjEzUHJaV1pMOWJOdVlZbktRbS1tSTBlNnRPbXBHa1dYSnFMMHFDQW9KcG9TMDZjWFZtclFueERiRFRXS0JNajBzQ0Jtd2E0ZGpJMkh1VUI1ZGdaT25ISm5NZmNYMFljemhCeDF4c0pBUUpsbk1fcGoyNnpLcXNmMUJnZHlKZi0zaGVGdjJ6NHc0M2dWS3VYMWRJSHF5SlVIeHViOXV0clo?oc=5", "source_name": "marketscreener.com", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Deploys $16 Billion in 60 Days: Is GILD Stock Undervalued for 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQSVFlVWF4b3BsZlAtbGZmaWFxVXRfQ0V4Z0F5elpteGYzWHhvWWpxV2lKejRmTkItNDF3SDlTcXdidm1qeTRNeEU1Vl9hUGdXWlp0MVpySlFoQlVXbTFQalVWdTU3Uld1SHUxZ212MGZmakVDSUZHNmREZmN0N2IyY1FLWFNzVXFQVG1JVWM2YlFQTEtpNkNYbjg5d0JiNUp2YkYyd180dktEUQ?oc=5", "source_name": "TIKR.com", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9AFBVV95cUxQOEdkMTFoTzJ5NEhuRk44MWZDOWNPNFBlLTNRN2VtZWhhc214NUV1N09RckNrbUxidEsxNnJhaXVzWVBJcC1kWXBMejZmMW1kWUp6UU5qb2MyMVhsQkJwNnNGSmZETkg4Q0gwV1I2WmRycWNseWYyUEFZUndmcm8xSWp3bjBway14T29KbWpuLU9YUUszVVhPVXFXcS1RT1FQNUE1Rm4wNmJPTlpOaVR0UDRxRXc4bFBHb1EzQ2x5aEFrbTk1bXJoR1VsVUVhbE9oOUNXSlVpeWxNQmFzTXAyLUdueXRleWNMOHVRZEY2c1VWbVNl?oc=5", "source_name": "Business Wire", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead extends Arcellx tender offer again (GILD:NASDAQ)", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxPOUtYRGxPRGttbWx3Si1QQjRWZG5pQ2huT0VIeTBKbGR4ZG1NeXRwUXlXYmJIWE1mblZqYVc5VUNoeU1zdm9RU0N6RDAwdWxxNTg3a1U1SzQzUGxiY0NEUEtqQ0NkNzhKbk5neThlWDhuQTg4Mkg4RkNaU183VFF0Q3ZobEdoUQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead extends Arcellx tender offer to April 27", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNMXhBaDZWa1lLSEdnUmlKaktrdW5qZjhlaHdoTk50b2t5Q0Y4MXZQdUR6M19XRUJlT3RTQWY1RjZLRlBMbkxwX1pDbXNSZ3hpN1FGaWRPemRxc0Z0ZXFRTUQ0VjJoaTVFQklSSGphQWlXSE5DQk94SjBYblFpWk92X2NPTHNzbFI3dUg0OHM1WEUzejNwaEpnS0lkekM2anBQVEo2YWtfRQ?oc=5", "source_name": "Investing.com", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQRU1kVU9JTVpDcEpETGFpZGlxUWc1UnZhY3pvMzBsU3k3UV9PaWsxaTVYd3hqODZMZHJLT2kxbUFrM3hKWEpzMUNBOUpIelJVOWdIM1ozaW9hNHJic2RSanItaFZ0cXpRejhGRG9JOU50R3RielBFb05wTjhCcW1SYzNVOWlPUTExcUszWFpjUm50ZHVjOXd2T3I2d1g?oc=5", "source_name": "Market source", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coronavirus Treatment: Gilead's Remdesivir Clinical Testing, Timeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPLTNMODBGRUJBZ1ptRzhBU0hXV1VwWFVNZHRqZXZMTEVVWU85Z3g3b0xqcEJRUFlNQTAyRE9FdlVYM2FxMDNUUnBlMkxqZmk3TVFEeERrdlNBdzJXZ2QyX3JfUzU5VkRFM2EtX3NzVEtGcmRXZTVPZmpsb0xCdFBZY1A2MGlvRjRFb2VyVXd1akk5MV9vWXFvLS1ibFhYWm9wSmlFeTdiMHM?oc=5", "source_name": "Business Insider", "published_at": "2020-10-22T07:00:00+00:00", "published_display": "22 Oct 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences, Inc.: Target Price Consensus and Analysts Recommendations | GILD | US3755581036", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxQSWtHYXp5ZEd3UTM0bDhFbUROR0xNZmVONkZwZDZMaVFkMC02MVY3azdRNlZxVWVqSmtxdWh2ZWpmbHNPUnU0VXAyZkR0WHg3cVlXQzYxc1ZjZjNaV1RGZUFEdWZvM3M1aV9HWGgzSGxWR2xzcHJkUUF4Nm5iMWs3cG1Hem0?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-19T19:34:47+00:00", "published_display": "19 Aug 2020 19:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNeXdaLWxrMGF4NG5FWTk5YVB0UDVLb1lJWXlFQWxZcHQzcG4xRkxpRFdZa2ZQM2YyUHNGUDQyZmtDQzM0TjRBZDFHMW81d1hfR1ZQMHE1ZzJJRjdEY0NpeTJWNk1lcDYySlE1RG0zelZ3TkNZa0F3NnFPTHg3Sjc1aENJV1prUlYtNFROVDgxMVZJd2FYUlg2bVc1cw?oc=5", "source_name": "Market source", "published_at": "2026-07-17T22:00:04+00:00", "published_display": "17 Jul 2026 22:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Inc (GILD) Stock Up 3.5% but GF Value Says Overv", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOc2ItdkhkVzNwMGdOYjZWX1Q2dFFXNzRBT1h5SzJmWGl3QVFfNkhTR2FuU1B5RVUwQk9obVpqT0pPdzNzeWRfTDJxbzZQVjhBMkpCVTVpUi1aelZET2ZiOGhFalNrRjVJVGhZc1c5NG9mamcySXNmaE5nRm1oZnNfMlUwT0dQZE51SHcyOUR3SG15WFhrOElXeVFlbGw5VmJfbkhEYzhPVWl2ajUzZ05RV180eTJ0eDVmMnlPeU1EQkx4MEdDcy0yQzBHYw?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-16T21:35:27+00:00", "published_display": "16 Jul 2026 21:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences (NASDAQ: GILD) exec trades 3,000 shares under 10b5-1 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOZFYxNFltWHNNWXR0X0djdnRuVmRIV1IxLVdpRUpBOUZkZUZkNkkzQUJpZVAyVXFmNy1sRVVBdnpQWDlrTlNyZXZiaElvOHZuYjFuNHZnM1V0SUFqal9VNTNUX0kwZWx3b0JiOF9HVUpSS2J4WXZES3RWd0dOVHlhT3l4U3AxbVZIWWppeXVCUlhhYTZLUkpLV3V5SkY5UERINnFNcXBlSzFvelZZZktUaUo0RQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-16T20:55:08+00:00", "published_display": "16 Jul 2026 20:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Planned 3,000-share sale by Gilead (NASDAQ: GILD) shareholder Johanna Mercier", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNazZnaTl3TmFwNDR3MVdGc3h5eVNtbG82SFFaR2FvWU9iY3VCWlk0d0lVc2Rsb3kzamM0ck52aFhUVVRjc0RvUXlxVnBHd0tRUnlMaGFLbUtyV2c5VG0wV09HaVBQRHJYdE4yZy1ndk9uMFBJRHVwekQzb25DVjNoVGRiQkZDZ2FwTnRENXRSc2pTNERxOUxUMWp3OG0?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T20:13:43+00:00", "published_display": "15 Jul 2026 20:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences, Inc. (GILD) Stock Analysis: Promising 21.93% Upside Amid Strong Buy Ratings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxPLUE4TjFuWVFnYXp6R2NkZlhUblVRRkw5NTRpTGt0ZGhzZnBXQ09ZREFvTndDYTBEeDJveC1zMGk0R09Zb3EyNllpVm9vRmdtM2k2T3ByMy1uNFpTWENNT0p2TmxRcnlmd0E3bEFPbTM1eGN2Z1czNnY3UG0tdTF0ZUdhNXYxMnFkc0NwRVNyMlZENkNac0lvMHgtaGx1YkRjc2dEbmcxN21KNFZ3cHpHTGViOGVjMDIya1lmWkdPa29HaFI5VE5JazVQUi1GUTdESmJF?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:12:07+00:00", "published_display": "13 Jul 2026 09:12", "sentiment": "positive", "sentiment_pct": 95, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQclR2UzJHMm1iZG44T2dzUFpGQmh5aDVsYmI2ejZkVFk1amV2Y29QbmFCTEdzQXJvMzYwYzJoY2dvRV96RTJxQkt2dUJCV2pobDN0YnpHTmx5TlA3TnA2ZHdRM29KRkZJRjFxNEk3X3piWGFzU0FhV1ZabkFYcXZPcVNpMlpNYTFaelY5a3BnTkFfM0tBTDBsTmNPdlM?oc=5", "source_name": "Market source", "published_at": "2026-07-10T22:00:03+00:00", "published_display": "10 Jul 2026 22:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead (GILD) Stock Looks Below Fair Value But Earnings Already Look Priced In", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-09T07:00:00+00:00", "published_display": "09 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will Trodelvy\u2019s First-Line TNBC Approval Redefine Gilead Sciences\u2019 (GILD) Oncology-Led Investment Narrative?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQb1Y3U09pU3plcjhBLVR4YnlEWmpXY3dFRHI4NXlnck5mMjN2WTQ3X2IxYVlULUVSVGM2T1lFY2xIb0VqaE9rZ1NkWTBKS3FMTFpReDM5MlBZcEZfQ3lrNUxGNl9nRnBDV2cybE5LTUFJNUdIdklTRVRvbWNobkpkbU1ibDFXVkhGdjEtU2ZhdGJoUFBibldISDBB?oc=5", "source_name": "Market source", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Could This FDA Milestone Unlock Gilead\u2019s (GILD) Next Big Growth Driver?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQT29NS01sMmtTVjF4MDhFYXpGUU9yMTFVSjFIMXRkRGYxMEZXR294X2ZfU2lNbEhPQ1Qyd1hxM0JjUm00UDFfOVJEQk8xVWp3QldqRXVLb0RIZVFPdjNFUnhwS2hwbGhfVGliS0JoQzM0b3c5ZjFwQXRXNkcyS1VxRVpYMktLX2plTGdzbWtkVTUxemtfZHlCcTRn?oc=5", "source_name": "Market source", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Stock (GILD) Opinions on Recent Congressional Insider Activity", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPQk1DTTdDeWFIb0JSZWdIamtYVzlxcnJ5THpBM2lfR0VLQ1lqamRMVS16eThoOUcyZjA3UmpNTkVlVzdsYVJtV04tUy05S1NVQkZ5Q2hMa1NzUDQxUThNcU5Qc1hGSTV3NUs4eEg5azhEX0xyaWJGQm93UmFnejg2bk5UdUM3bGs2bWV6YTZ4WkJRX1RlTFR5QUI1TWNBZFpUZlMxekZYMHY4UmV2YlNHSHM1aTBpdw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences (GILD) Stock Falls Amid Market Uptick: What Investors Need to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQZ3RhTlFnWC1qTkw3YXFtQ0pBSmEtYW8zRGdPUzhJNVhQQjhBUmtlRkszQzJNaGM3MXlYb0tmV0tWWHNscG8yV1pIaXV0NnJLRVhpaF9Ub3NWYWxLOUdhQ2JrSnlkSnBHenloWGsxRUtDaHhReHNkZWVEVTA5di01ZmI3QVRVX09SREwzQkJfSUJVNGNEM1lrUVRsR3hrdw?oc=5", "source_name": "Market source", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reassess Gilead Sciences (GILD) After Strong Multi Year Share Price Gains", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNeV9feXBaekdJMVZzOEdEQzByUG1UTW0wdFRNYnhvOUxyWXR3ZDNIWWZrbmlCVEJXYWtFS1hXZndLT1g1VFVJVHlyNmNBZ0VXVVhKYVMzd2t1NS05dVZBbGcwVHI1b3NaRk5ZOEhoMW1yeTdxdWNhR0FrWFpmUUlOcHg3UkJmMUJDSHl1bW0yWWk1cm9tZmNCb21KUGo3NENP?oc=5", "source_name": "Market source", "published_at": "2026-05-23T07:00:00+00:00", "published_display": "23 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Just Told Investors What to Watch Before December 23. Here\u2019s What the Data Says About GILD Stock.", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQMy1FZks3blJfcHlFUXMxclRvdWtELUZ1Vk80amFiMlJKUGdIamE3UjJmX3JmOXpUN2ZTRXBEWm5JdF9KejJXMW5DZ1k5MDlydTZUdkVxUlVUQ1JIN3I0WVowTlRRS1dscGtKOC1tQjNLZjd5dGNEanZweFp3UUsxc193blRFZjR2WjFMTVBvbUc1NS1Td29wZ0U2azEwR3IwZTdlMk9IdUhVWllacHFmVl9lR2RJNThRbWhEMjZIV2x2RUpieW83VE4xTE1mb0dmb0E?oc=5", "source_name": "TIKR.com", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Flash (GILD) Gilead Sciences, Inc. Posts Q1 Adjusted EPS $2.03 per Share", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPYnNLU0htTl9FcTZGaFJuYlhSMGplVmUxSVkxS0ZBRkJXZ0tjQk5wNVR0SDdSMGN4aklSRHFmcXNqQkZTZDJvNUhEMGF3cXVOWFI2a3dGemlIOXMtM0NIRG9LejRXdVRicmV1Rm5qQWx5Y1pENnRnXzRpWXlHNXVMY1k4RlZYWlVRNVk0ejA1bDBTSDNwVjUtU0FhOXZRcF9LRVY5WHJkX3Q1ZlZxY3FGMU1ha3BIQWJpYmxCUTBRRGJhMUczajRXcg?oc=5", "source_name": "marketscreener.com", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences CEO Daniel O\u2019Day sells over $1.29m in stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQQnJpbXFWRlo2a2NaaDVUTVhhdHJZU0ozLVFJOGREVEFqVXZoTV9XbWRabHJxYVRXcF93bGN0UWFyc0lwWFdVZUZoVnBEMkNqZ0xUVFliU05Kb2pKZVVoV0FqYVJtaGIyRDBhX3Z5eWZrSnJsSmhScVRHNGZjNDYxRWpUVHVENjJsYUZ6WkdIalRiNUpsTDdrWDZ4VTd1c0VPNWRpYThkYy1pdVZCM210dnFjRUJ3VFVFUmlhV2V3?oc=5", "source_name": "Investing.com", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences (GILD) Stock Lands $7.8B Arcellx Deal \u2014 Is This the Buy Opportunity?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQTUtvY0RKaUd0aG1LUC1YRC1KVHZULTFJa1ZmQ2kxOWlBT25oZ0tpQUVUeFJfclBXQWpWaTZ4U0x4b0JXVFEwYTRDQmNfc2JnczgxUjQzQVhjZGRialRfSkZfMDBmMW41Wm56UkJKdW4wR0R4Q1pGY3ZQazUxUzFBUDVTOWNvT1g4MnZLRk9jd21xQzFQWHZmSHE2REk4bktvSGdhV1ln?oc=5", "source_name": "CoinCentral", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Inc. (GILD): Growing Popularity as Defensive Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOMS1kN2xmaTh4MTlPODdvOE12di05bS1RbFhpNHg2dDJGSXlZYXV1T2MzNEYzZUMwQnB2YWZVNnZEdE51SjdFdE1nSDRRajh3Xzd4V2x1Smc1NTVFUG0xQlBjRU1ZbWUtUWE2VG03VUx2dXE0Unk1R2Nfc0VVRkFpZkh2LVZZQmlTM1lBem5xYWxVeFNUYnlCbkNIdEdEQQ?oc=5", "source_name": "Market source", "published_at": "2026-04-26T07:00:00+00:00", "published_display": "26 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences : Publishes 2025 Responsible Business and Impact Report, Highlighting Momentum Toward 2030 Ambitions", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxQZE95dkczUkh1bG05TU1uaFlPMGtZTktFSEo5djhzU1BiUEdHd3lLeTB0bDJNOWZodmY1SUlVZ0NaQUE4RjEzUHJaV1pMOWJOdVlZbktRbS1tSTBlNnRPbXBHa1dYSnFMMHFDQW9KcG9TMDZjWFZtclFueERiRFRXS0JNajBzQ0Jtd2E0ZGpJMkh1VUI1ZGdaT25ISm5NZmNYMFljemhCeDF4c0pBUUpsbk1fcGoyNnpLcXNmMUJnZHlKZi0zaGVGdjJ6NHc0M2dWS3VYMWRJSHF5SlVIeHViOXV0clo?oc=5", "source_name": "marketscreener.com", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Deploys $16 Billion in 60 Days: Is GILD Stock Undervalued for 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQSVFlVWF4b3BsZlAtbGZmaWFxVXRfQ0V4Z0F5elpteGYzWHhvWWpxV2lKejRmTkItNDF3SDlTcXdidm1qeTRNeEU1Vl9hUGdXWlp0MVpySlFoQlVXbTFQalVWdTU3Uld1SHUxZ212MGZmakVDSUZHNmREZmN0N2IyY1FLWFNzVXFQVG1JVWM2YlFQTEtpNkNYbjg5d0JiNUp2YkYyd180dktEUQ?oc=5", "source_name": "TIKR.com", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9AFBVV95cUxQOEdkMTFoTzJ5NEhuRk44MWZDOWNPNFBlLTNRN2VtZWhhc214NUV1N09RckNrbUxidEsxNnJhaXVzWVBJcC1kWXBMejZmMW1kWUp6UU5qb2MyMVhsQkJwNnNGSmZETkg4Q0gwV1I2WmRycWNseWYyUEFZUndmcm8xSWp3bjBway14T29KbWpuLU9YUUszVVhPVXFXcS1RT1FQNUE1Rm4wNmJPTlpOaVR0UDRxRXc4bFBHb1EzQ2x5aEFrbTk1bXJoR1VsVUVhbE9oOUNXSlVpeWxNQmFzTXAyLUdueXRleWNMOHVRZEY2c1VWbVNl?oc=5", "source_name": "Business Wire", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead extends Arcellx tender offer again (GILD:NASDAQ)", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxPOUtYRGxPRGttbWx3Si1QQjRWZG5pQ2huT0VIeTBKbGR4ZG1NeXRwUXlXYmJIWE1mblZqYVc5VUNoeU1zdm9RU0N6RDAwdWxxNTg3a1U1SzQzUGxiY0NEUEtqQ0NkNzhKbk5neThlWDhuQTg4Mkg4RkNaU183VFF0Q3ZobEdoUQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead extends Arcellx tender offer to April 27", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNMXhBaDZWa1lLSEdnUmlKaktrdW5qZjhlaHdoTk50b2t5Q0Y4MXZQdUR6M19XRUJlT3RTQWY1RjZLRlBMbkxwX1pDbXNSZ3hpN1FGaWRPemRxc0Z0ZXFRTUQ0VjJoaTVFQklSSGphQWlXSE5DQk94SjBYblFpWk92X2NPTHNzbFI3dUg0OHM1WEUzejNwaEpnS0lkekM2anBQVEo2YWtfRQ?oc=5", "source_name": "Investing.com", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQRU1kVU9JTVpDcEpETGFpZGlxUWc1UnZhY3pvMzBsU3k3UV9PaWsxaTVYd3hqODZMZHJLT2kxbUFrM3hKWEpzMUNBOUpIelJVOWdIM1ozaW9hNHJic2RSanItaFZ0cXpRejhGRG9JOU50R3RielBFb05wTjhCcW1SYzNVOWlPUTExcUszWFpjUm50ZHVjOXd2T3I2d1g?oc=5", "source_name": "Market source", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coronavirus Treatment: Gilead's Remdesivir Clinical Testing, Timeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPLTNMODBGRUJBZ1ptRzhBU0hXV1VwWFVNZHRqZXZMTEVVWU85Z3g3b0xqcEJRUFlNQTAyRE9FdlVYM2FxMDNUUnBlMkxqZmk3TVFEeERrdlNBdzJXZ2QyX3JfUzU5VkRFM2EtX3NzVEtGcmRXZTVPZmpsb0xCdFBZY1A2MGlvRjRFb2VyVXd1akk5MV9vWXFvLS1ibFhYWm9wSmlFeTdiMHM?oc=5", "source_name": "Business Insider", "published_at": "2020-10-22T07:00:00+00:00", "published_display": "22 Oct 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences, Inc.: Target Price Consensus and Analysts Recommendations | GILD | US3755581036", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxQSWtHYXp5ZEd3UTM0bDhFbUROR0xNZmVONkZwZDZMaVFkMC02MVY3azdRNlZxVWVqSmtxdWh2ZWpmbHNPUnU0VXAyZkR0WHg3cVlXQzYxc1ZjZjNaV1RGZUFEdWZvM3M1aV9HWGgzSGxWR2xzcHJkUUF4Nm5iMWs3cG1Hem0?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-19T19:34:47+00:00", "published_display": "19 Aug 2020 19:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 86, "total_relevant": 25, "sentiment_summary": {"positive": 5, "negative": 1, "neutral": 19, "score": 54, "total": 25, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 87, "events": [{"event": "general", "label": "Market update", "weight": 10.8, "count": 19}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 5, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 114.86, "latest_week": "2026-07-10", "one_week_move": 0.6, "four_week_move": 6.2, "twelve_week_move": -0.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.235284, "market_dynamics_buy_signal": false, "relative_strength": -13.472466, "fair_value_gap": 34.6, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "positive", "expectation_probability": 55.2253, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.6% over one week, +6.2% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 55, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 8}, {"label": "marketscreener.com", "count": 3}, {"label": "Stock Titan", "count": 2}, {"label": "TIKR.com", "count": 2}, {"label": "Investing.com", "count": 2}, {"label": "GuruFocus", "count": 1}, {"label": "DirectorsTalk Interviews", "count": 1}, {"label": "simplywall.st", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 25}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 19}, {"label": "Earnings", "count": 2}, {"label": "Deals and strategy", "count": 2}, {"label": "Regulatory and legal", "count": 1}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "87/100 classification confidence."}, {"label": "Company focus", "value": "25", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.6% over one week, +6.2% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know"}], "updated_at": "2026-07-18T13:42:39.176132+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}